Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1840 1
1851 1
1858 1
1859 1
1880 1
1890 1
1894 1
1900 1
1906 1
1961 1
1968 1
1971 1
1974 1
1993 1
1998 2
2000 1
2002 3
2003 3
2004 8
2005 4
2006 11
2007 6
2008 10
2009 8
2010 2
2011 2
2012 8
2013 4
2014 3
2015 4
2016 6
2017 1
2018 4
2019 2
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 12214238

108 results

Results by year

Filters applied: . Clear all
Page 1
RNA as drug and antidote.
Tuddenham E. Tuddenham E. Nature. 2002 Sep 5;419(6902):23-4. doi: 10.1038/419023a. Nature. 2002. PMID: 12214216 No abstract available.
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
Dyke CK, Steinhubl SR, Kleiman NS, Cannon RO, Aberle LG, Lin M, Myles SK, Melloni C, Harrington RA, Alexander JH, Becker RC, Rusconi CP. Dyke CK, et al. Circulation. 2006 Dec 5;114(23):2490-7. doi: 10.1161/CIRCULATIONAHA.106.668434. Epub 2006 Nov 13. Circulation. 2006. PMID: 17101847 Clinical Trial.
The potential of aptamers as anticoagulants.
Nimjee SM, Rusconi CP, Harrington RA, Sullenger BA. Nimjee SM, et al. Trends Cardiovasc Med. 2005 Jan;15(1):41-5. doi: 10.1016/j.tcm.2005.01.002. Trends Cardiovasc Med. 2005. PMID: 15795162 Review.
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
Chan MY, Cohen MG, Dyke CK, Myles SK, Aberle LG, Lin M, Walder J, Steinhubl SR, Gilchrist IC, Kleiman NS, Vorchheimer DA, Chronos N, Melloni C, Alexander JH, Harrington RA, Tonkens RM, Becker RC, Rusconi CP. Chan MY, et al. Circulation. 2008 Jun 3;117(22):2865-74. doi: 10.1161/CIRCULATIONAHA.107.745687. Epub 2008 May 27. Circulation. 2008. PMID: 18506005 Clinical Trial.
108 results